Can Obama Help Vete...
Affymetrix Inc. (AFFX: NASDAQ)
$4.57 -0.17 | -3.59%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 29.60 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 107.70 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 18.60 | 12.50 |
| Beta | 2.03 | 1.21 | 0.98 |
| Price to Sales (TTM) | 1.24 | 2.24 | 1.42 |
| Price to Book (MRQ) | 1.18 | 2.96 | 2.41 |
| Price to Tangible Book (MRQ) | 1.31 | 6.32 | 5.08 |
| Price to Cash Flow (TTM) | -313.00 | 16.90 | 9.80 |
| Price to Free Cash Flow (TTM) | 16.40 | 145.50 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.90 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.40 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 16.68 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 11.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | -11.50 | 19.50 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -13.90 | 8.30 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | -6.41 | -5.39 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | -100.00 | 4.30 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | -100.00 | 4.30 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | -0.28 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -38.38 | -3.67 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 3.40 | 1.70 | 1.10 |
| Current Ratio (MRQ) | 4.50 | 2.40 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.20 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.27 | 0.96 |
| Interest Coverage (TTM) | n.a. | 9.00 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 69.20 | 50.10 | 46.90 |
| Gross Margin - 5 Yr Avg | 71.30 | 47.20 | 47.70 |
| EBITD Margin (TTM) | 3.20 | 17.30 | 18.90 |
| EBITD - 5 Yr Avg | 14.43 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -12.10 | 10.40 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -16.80 | 9.10 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -0.13 | 0.09 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -21.20 | 8.00 | 7.00 |
| Return on Assets (TTM) | -9.70 | 6.30 | 3.10 |
| Return on Assets - 5 Yr Avg | -10.60 | 5.40 | 2.50 |
| Return on Investment (TTM) | -11.00 | 9.00 | 7.90 |
| Return on Investment - 5 Yr Avg | -12.10 | 7.50 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 295,997.00 | 222,784.00 | 449,376.00 |
| Net Income/Employee (TTM) | -37,048.00 | 19,812.00 | 39,003.00 |
| Receivable Turnover (TTM) | 5.40 | 5.50 | 7.60 |
| Inventory Turnover (TTM) | 1.80 | 3.20 | 8.30 |
| Asset Turnover (TTM) | 0.70 | 0.80 | 0.40 |
Portfolios with AFFX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserPART 7 JPMorgan 28th Annual...
- UserStockpickrOne
- UserLast Day of the JPMorgan He...
- ContributorFast Money's First 100 Days...
- ContributorBarron's Cheap Losers For A...
Latest AFFX Headlines from TheStreet
- Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 10:05 pm
- Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.08.12 | 10:02 pm
- 5 Stocks Set to Soar on Bullish Earnings 02.07.12 | 06:02 am
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.19.11 | 03:12 pm
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.09.11 | 10:12 am
- Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 08:11 pm
- ServiceSource, Illumina: After-Hours Trading 10.06.11 | 06:10 pm
- Affymetrix Inc. Stock Downgraded (AFFX) 08.05.11 | 07:08 am
- Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.27.11 | 11:07 pm
- 5 More Earnings Stocks Set to Soar 07.27.11 | 11:07 am
Press Releases for AFFX
- Affymetrix And Leica Microsystems Announce Worldwide Collaboration On Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay For Research Use - Business Wire 05.31.12 | 07:05 am
- Affymetrix And ScreenCell Announce Worldwide Distribution Agreement For Circulating Tumor Cell (CTC) Technology - Business Wire 05.17.12 | 07:05 am
- Affymetrix To Webcast Annual Meeting Of Shareholders - Business Wire 05.11.12 | 09:05 am
- Affymetrix And EBioscience Amend Definitive Merger Agreement - Business Wire 05.03.12 | 10:05 pm
- Affymetrix Reports First Quarter 2012 Results - Business Wire 05.03.12 | 04:05 pm
- Affymetrix To Host Conference Call On May 3, 2012 To Announce First Quarter 2012 Operating Results - Business Wire 04.17.12 | 04:04 pm
- Affymetrix Announces A Global Distribution Agreement With Almac To Distribute Its Proprietary Xcel™ Array For Translational Research Applications - Business Wire 03.29.12 | 07:03 am
- Lineagen Applies Affymetrix' GeneChip® Technology To Next-Generation FirstStepDx® Service For Individuals With Developmental Delay And Autism Spectrum Disorders - PR Newswire 03.28.12 | 07:03 am
- Affymetrix Axiom(R) Exome Genotyping Arrays (Photo: Business Wire) - Business Wire 02.23.12 | 09:02 am
- China Clears Its First Microarray Platform For In Vitro Diagnostics To Accelerate Personalized Medicine - Business Wire 02.15.12 | 06:02 pm
Partner Headlines for AFFX
- Affymetrix Inks Distribution Pact - Analyst Blog - Zacks 05.21.12 | 07:05 pm
- Benzinga's Top Upgrades with Color for May 9, 2012 - Benzinga 05.09.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 03.16.12 | 09:03 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 03.12.12 | 09:03 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.08.12 | 09:03 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 02.14.12 | 09:02 am
- Luminex Beats on Assay Boost - Analyst Blog - Zacks 02.07.12 | 09:02 am
- UPDATE: Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am
- Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am





